Halo Pharma Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Halo Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013377
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Halo Pharma Inc (Halo) is a contract development and manufacturing organization which offers scientific and development expertise services. It offers project management, formulation development and analytical development services. The organization holds specialization in the development of mini and micro tablets, pellets, beads, powders, capsules, stick pack, liquid suspensions, semi-solid ointments, gels and creams, among others. Halo also offers solids, liquids and sterile ointment; and packaging services. The company offers testing services through contract development, during commercial manufacturing; and throughout the product lifecycle to support manufacturing. Its dosage forms comprise sterile, ophthalmic ointments and topical gels, non-sterile, controlled drugs, and others. Halo is headquartered in Whippany, New Jersey, the US.

Halo Pharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Halo Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
Halo Pharma Completes Acquisition Of Mirabel Manufacturing Facility From Teva Canada 9
Private Equity 10
SK Capital Acquires Majority Stake in Halo Pharma 10
Partnerships 11
ExxPharma Therapeutics Enters into Agreement with Halo Pharma 11
Acquisition 12
Halo Pharma Acquires Minority Stake In Altus Formulation 12
Halo Pharma Inc – Key Competitors 13
Halo Pharma Inc – Key Employees 14
Halo Pharma Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Corporate Communications 16
Jun 27, 2017: Halo Pharma Welcomes Itzhak Krinsky, Ph.D. to Its Board of Directors 16
Other Significant Developments 17
May 10, 2017: Halo Pharma Announces the Formation of Its Pediatric Center of Excellence for the Development, Reformulation, and Manufacturing of Drug Products in Pediatric Dosage Forms 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Halo Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Halo Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Halo Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Halo Pharma Completes Acquisition Of Mirabel Manufacturing Facility From Teva Canada 9
SK Capital Acquires Majority Stake in Halo Pharma 10
ExxPharma Therapeutics Enters into Agreement with Halo Pharma 11
Halo Pharma Acquires Minority Stake In Altus Formulation 12
Halo Pharma Inc, Key Competitors 13
Halo Pharma Inc, Key Employees 14
Halo Pharma Inc, Subsidiaries 15

★海外企業調査レポート[Halo Pharma Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Macquarie Bank Ltd:企業のM&A・事業提携・投資動向
    Macquarie Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Macquarie Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Plansee Holding AG:企業の戦略・SWOT・財務分析
    Plansee Holding AG - Strategy, SWOT and Corporate Finance Report Summary Plansee Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Clark Enterprises Inc:企業の戦略・SWOT・財務情報
    Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Clark Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bio-Rad Laboratories, Inc.:企業の戦略・SWOT・財務分析
    Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report Summary Bio-Rad Laboratories, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Accuray Inc (ARAY):医療機器:M&Aディール及び事業提携情報
    Summary Accuray Inc (Accuray) carries out the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. The company’s major produc …
  • Passenger Rail Agency of South Africa:企業の戦略的SWOT分析
    Passenger Rail Agency of South Africa - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Yangarra Resources Ltd (YGR):石油・ガス:M&Aディール及び事業提携情報
    Summary Yangarra Resources Ltd (Yangarra) is an oil and gas company that explores, develops and produces oil and natural gas resources. The company owns and operates oil and gas properties in Medicine Hat, Central Alberta, and Jaslan. It has infrastructure and land holdings. Central Alberta producti …
  • Western Area Power Administration:企業の戦略的SWOT分析
    Western Area Power Administration - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Petroleum Development Oman LLC:企業の戦略的SWOT分析
    Petroleum Development Oman LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Rabobank Group:企業のM&A・事業提携・投資動向
    Rabobank Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rabobank Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • U-Haul International Inc:企業の戦略的SWOT分析
    U-Haul International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • ProMetic Life Sciences Inc (PLI):製薬・医療:M&Aディール及び事業提携情報
    Summary ProMetic Life Sciences Inc (ProMetic) is a biopharmaceutical company that focuses on bioseparations, plasma-derived therapeutics and small-molecule drug development. The company develop products for the treatment for fibrosis, anemia, autoimmune diseases, inflammation and nephropathies. The …
  • Guangshen Railway Company Limited:戦略・SWOT・企業財務分析
    Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report Summary Guangshen Railway Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Genesis Energy Ltd (GNE):電力:M&Aディール及び事業提携情報
    Summary Genesis Energy Ltd (Genesis) is an energy company. It generates electricity and supplies that on retail and wholesale basis. The company also supplies gas and LPG, and related services to end-users; and sells and purchases electricity derivatives. Genesis produces power using coal, gas, hydr …
  • Panasonic Corp (6752):企業の財務・戦略的SWOT分析
    Panasonic Corp (6752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Neuwave Medical Inc-医療機器分野:企業M&A・提携分析
    Summary NeuWave Medical Inc (NeuWave), a subsidiary of Ethicon US LLC is a medical device company that develops and commercializes energy-based minimally invasive medical devices. Its flagship product, Certus 140 microwave ablation (coagulation) system, is a minimally invasive soft tissue ablation s …
  • China National Offshore Oil Corp:企業の戦略的SWOT分析
    China National Offshore Oil Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Mindray Medical International Ltd-医療機器分野:企業M&A・提携分析
    Summary Mindray Medical International Ltd (Mindray) is a medical device company. Its major products include multi-parameter patient monitors, telemetry monitoring system, defibrillator, anesthesia machine, surgical lights, ceiling supply units, veterinary monitoring systems, hematology analyzer and …
  • Immunovia AB (IMMNOV):企業の財務・戦略的SWOT分析
    Summary Immunovia AB (Immunovia) is a molecular diagnostics company that offers clinical testing for early diagnosis of pancreatic cancer. The company develops IMMray, a technology platform based on antibody microarray analysis, which can be used in the early diagnosis of cancer, predicting disease …
  • EnBW Energie Baden-Wurttemberg AG (EBK):企業の財務・戦略的SWOT分析
    EnBW Energie Baden-Wurttemberg AG (EBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆